Lipid-encapsulated mRNA encoding an extended serum half-life interleukin-22 ameliorates metabolic disease in mice
Susanna Canali(Moderna Therapeutics (United States)), Eric Yi‐Hsiu Huang(National Yang Ming Chiao Tung University), Meagan L. Goodridge(Moderna Therapeutics (United States)), Nancy Dussault(Moderna Therapeutics (United States)), Sze-Wah Tse(Moderna Therapeutics (United States)), Anne-Renee Graham(Moderna Therapeutics (United States)), Veronica Ritchie(Moderna Therapeutics (United States)), Karl E. Anderson(The University of Texas Medical Branch at Galveston), Alexander W. Fischer(Universität Hamburg), Jared Iacovelli(Penn Presbyterian Medical Center), Todd Sparrow(Moderna Therapeutics (United States)), Allison Pannoni(Moderna Therapeutics (United States)), Kaitlin Klovdahl(Moderna Therapeutics (United States)), Chinmayi Bankar(Moderna Therapeutics (United States)), Vivienne Woo(Cincinnati Children's Hospital Medical Center), Lorna Wu(Moderna Therapeutics (United States)), Chiaowen Joyce Hsiao(Moderna Therapeutics (United States))
Cited by 5
Related Papers
Defining Translational Research: Implications for Training
|Academic Medicine|2010|670
Epigenetic regulation by gut microbiota
|Gut Microbes|2022|313
FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues
|Cell Metabolism|2016|255
Microbiota-derived metabolite promotes HDAC3 activity in the gut
|Nature|2020|254
Stimulatory effect of brussels sprouts and cabbage on human drug metabolism
|Clinical Pharmacology & Therapeutics|1979|242